Infection or Malignancy? A Novel Co-Diagnosis in a Patient After Hematopoietic Stem Cell Transplant

Rachel L. Medernach, Vivek Paul*, Michael Angarone

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Patients undergoing hematopoietic stem cell transplant are susceptible to various opportunistic infections after transplantation, including reactivation of latent infections. We report a patient with acute neurologic worsening after allogeneic hematopoietic stem cell transplant complicated by chronic graft-versus-host disease who was concurrently diagnosed with cerebral toxoplasmosis and post-transplant lymphoproliferative disorder with central nervous system involvement, the first such reported co-diagnosis to our knowledge. Management of these patients can be challenging due to the continued need for immunosuppression to control graft-versus-host disease. Due to the high mortality associated with either condition, this co-diagnosis ultimately proved fatal in our patient.

Original languageEnglish (US)
Article numbere231140
JournalAnnals of Internal Medicine Clinical Cases
Volume3
Issue number3
DOIs
StatePublished - Mar 2024

Keywords

  • Brain
  • Central nervous system
  • Graft-versus-host disease
  • Hematopoietic stem cell transplantation
  • Hematopoietic stem cells
  • Mortality
  • Opportunistic infections
  • Post-transplant lymphoproliferative disorders
  • Toxoplasma
  • Toxoplasmosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Infection or Malignancy? A Novel Co-Diagnosis in a Patient After Hematopoietic Stem Cell Transplant'. Together they form a unique fingerprint.

Cite this